The Paediatric Rheumatology International Trials Organization (PRINTO)

Lupus

Volumn 16, Issue 8, 2007, Pages 670-676

  Ruperto, Nicolino ^a   Bazso, A ^a   Ravelli, A ^a   Malattia, C ^a   Filocamo, G ^a   Pistorio, A ^a   Rodriguez Lozano, A L ^a   Viola, S ^a   Martini, A ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Clinical trials; Juvenile systemic lupus erythematosus; Response to therapy

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

CLINICAL PRACTICE; CLINICAL TRIAL; CONSTRUCT VALIDITY; DISEASE ACTIVITY; HEALTH CARE ORGANIZATION; HUMAN; PRIORITY JOURNAL; PROTEINURIA; QUALITY OF LIFE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; WELLBEING;

ADOLESCENT; CHILD; CLINICAL TRIALS AS TOPIC; HUMANS; INTERNATIONAL COOPERATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; TREATMENT OUTCOME;

EID: 34548380925     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307079556     Document Type: Review

References (40)

1. Flanc RS, Roberts MA, Strippoli GFM, Chadban SJ, Kerr PG, Atkins RC. Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials. Am J Kidney Dis 2004; 43: 197-208.
2. Contreras G, Pardo V, Leclercq B et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004; 350: 971-980.
3. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol 1999; 26: 490-497.
4. Smolen JS, Strand V, Cardiel M, et al. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: Consensus on a preliminary core set of outcome domains. J Rheumatol 1999; 26: 504-507.
5. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 2004; 50: 3418-3426.
6. Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: report of a consensus meeting. Arthritis Rheum 2004; 50: 3427-3431.
7. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006; 54: 421-432.
8. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34: 866-872.
9. Font J, Cervera R, Espinosa G et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 456-459.
10. Carreno L, Lopez-Longo FJ, Monteagudo I et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus 1999; 8: 287-292.
11. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus - Cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002; 46: 436-444.
12. Ravelli A, Duarte-Salazar C, Buratti S et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: A multicenter cohort study. Arthritis Rheum Arthritis Care Res 2003; 49: 501-507.
13. Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004; 16: 566-570.
14. Ruperto N, Ravelli A, Murray KJ et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003; 42: 1452-1459.
15. Ruperto N, Ravelli A, Cuttica R et al. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set. Arthritis Rheum 2005; 52: 2854-2864.
16. Ruperto N, Ravelli A, Oliveira S et al. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus. Prospective validation of the definition of improvement. Arthritis Rheum 2006; 55: 355-363.
17. Delbecq AL, Van de Ven AH, Gustafson DH. Group techniques for program planning. A guide to nominal group and Delphi processes, 1st edition. Scott, Foresman and Company, 1975.
18. Sniderman AD. Clinical trials, consensus conferences, and clinical practice. Lancet 1999; 354: 327-330.
19. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202-1209.
20. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-735.
21. Rider LG, Giannini EH, Harris-Love M et al. Defining clinical improvement in adult and juvenile myositis. J Rheumatol 2003; 30: 603-617.
22. Rider LG, Giannini EH, Brunner HI et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004; 50: 2281-2290.
23. Oddis CV, Rider LG, Reed AM et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 2005; 52: 2607-2615.
24. Martini A, Ruperto N, Lovell DJ, Giannini EH, for the Paediatric Rheumatology International Trials Organisation (PRINTO), and for the Pediatric Rheumatology Collaborative Study Group (PRCSG). An international Consensus Conference to define core sets of outcome measures for juvenile systemic lupus erythematosus and juvenile dermatomyositis. Conference proceedings; Pavia, Italy, "Almo Collegio Borromeo", 31 March-3 April 2001. PRINTO proceedings; Pavia, Italy, IRCCS S. Matteo: Paediatric Rheumatology International Trials Organisation (PRINTO); 2001: p 1-134.
25. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
26. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
27. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
28. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.
29. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 541-547.
30. Vitali C, Bencivelli W, Mosca M, Carrai P, Sereni M, Bombardieri S. Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus. J Rheumatol 1999; 26: 498-501.
31. Landgraf JM, Abetz L, Ware JE. The CHQ user's manual, 1st edition. The Health Institute, New England Medical Center, 1996.
32. Ruperto N, Ravelli A, Pistorio A et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol 2001; 19: S1-S9.
33. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37: 1761-1769.
34. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998; 25: 198-199.
35. Bellamy N. Clinimetric concepts in outcome assessment: The OMERACT filter. J Rheumatol 1999; 26: 948-950.
36. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28: 632-642.
37. Cronbach LJ. Coefficient alfa and the internal structure of tests. Psychometrika 1951; 16:297-334.
38. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283-298.
39. Cohen J. Statistical power analysis for the behavioral sciences. Academic Press, 1977.
40. Landis JR, Koch GC. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.